Premium Nahrungsergänzungsmittel | artgerecht

Pancreolauryl Test – Pancreatic Function Testing

The pancreolauryl test is a non-invasive urine-based diagnostic test used to assess the exocrine function of the pancreas. It helps detect pancreatic insufficiency at an early stage.

Regular tips about health Regular tips about health

Things worth knowing about "Pancreolauryl Test"

The pancreolauryl test is a non-invasive urine-based diagnostic test used to assess the exocrine function of the pancreas. It helps detect pancreatic insufficiency at an early stage.

What Is the Pancreolauryl Test?

The pancreolauryl test is an indirect function test used to evaluate the exocrine function of the pancreas. The exocrine pancreas produces digestive enzymes essential for breaking down fats, proteins, and carbohydrates in the small intestine. When the pancreas is damaged or diseased, this function may become impaired, resulting in exocrine pancreatic insufficiency (EPI).

How Does the Test Work?

The pancreolauryl test is based on the enzymatic cleavage of a specific test substance by the pancreatic enzyme cholesterol esterase (arylesterase). On the first test day, the patient swallows a capsule containing fluorescein dilaurate, an ester that is cleaved exclusively by cholesterol esterase in the small intestine. The released fluorescein is then conjugated in the liver and excreted in the urine.

On the second test day (reference day), the patient ingests free fluorescein, which is absorbed and excreted directly without enzymatic cleavage. This provides a reference value that accounts for the individual absorption and excretion capacity of the patient.

A pancreolauryl ratio is calculated from the fluorescein excretion on both days, reflecting the level of pancreatic enzyme activity.

When Is the Pancreolauryl Test Used?

Suspected chronic pancreatitis (long-term inflammation of the pancreas)
Investigation of persistent diarrhea, fatty stools (steatorrhea), and unexplained weight loss
Monitoring the progression of known exocrine pancreatic insufficiency
Follow-up after pancreatic surgery or in conditions such as cystic fibrosis
Differential diagnosis of nutritional deficiencies and malabsorption syndromes

Preparation and Procedure

The test is conducted over two consecutive days. Patients should fast before each test day. After taking the test substance, urine is collected over a defined period (usually 10 hours) and the fluorescein concentration is measured. Certain medications, foods, or underlying conditions such as kidney disease or liver disorders may affect the test results and should be considered before testing.

Interpretation of Results

A low pancreolauryl ratio (below the defined threshold) indicates reduced cholesterol esterase activity and suggests impaired exocrine pancreatic function. A normal ratio argues against severe exocrine pancreatic insufficiency. It is important to note that the test reliably identifies severe dysfunction, while mild to moderate impairments may not always be detected accurately.

Advantages and Limitations

Non-invasive: No endoscopy or biopsy required
Outpatient-friendly: No hospital admission needed
Simple procedure: Only requires capsule ingestion and urine collection
Limited sensitivity: Mild pancreatic insufficiency may be missed
Confounding factors: Kidney disease, liver disorders, intestinal conditions, and certain medications can affect accuracy

Alternatives and Complementary Diagnostics

Other diagnostic methods are available to assess pancreatic function, including fecal pancreatic elastase-1 measurement (a simpler and more commonly used test), the secretin-cholecystokinin stimulation test (the gold standard but invasive), and imaging techniques such as ultrasound, CT, or MRI of the abdomen.

References

Dominguez-Munoz JE. Pancreatic exocrine insufficiency: diagnosis and treatment. Journal of Gastroenterology and Hepatology, 2011; 26 Suppl 2:12-16.
Loser C, Mollgaard A, Folsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut, 1996; 39(4):580-586.
Ewald N, Hardt PD. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World Journal of Gastroenterology, 2013; 19(42):7276-7281.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.